Noah G. Levy

This profile gathers the share dealings of Noah G. Levy in Merrimack Pharmaceuticals Inc, where the filings describe the role as board member. We count 40 filings; the first trade dates from 3 April 2020 and the latest from 12 January 2023.

On the market, this insider has only ever bought: 40 purchases, €2.5M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2023, the count stands at 2 purchases and no sales.

In size, the median ticket on the buying side is €14k. On 36 out of 40 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 17 January 2023: an open-market purchase of €1.1M, in Merrimack Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.